<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://respiratory-research.com/feeds/latestcomments/journal?quantity=&amp;format=rss&amp;version=">
        <title>Respiratory Research - Latest Comments</title>
        <link>http://respiratory-research.com/comments</link>
        <description>The latest comments on all articles published by Respiratory Research</description>
        <dc:date>2008-03-04T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li resource="http://respiratory-research.com/content/8/1/58" />
                                <rdf:li resource="http://respiratory-research.com/content/8/1/58" />
                                <rdf:li resource="http://respiratory-research.com/content/7/1/81" />
                                <rdf:li resource="http://respiratory-research.com/content/6/1/135" />
                                <rdf:li resource="http://respiratory-research.com/content/5/1/22" />
                                <rdf:li resource="http://respiratory-research.com/content/5/1/22" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://respiratory-research.com/content/8/1/58/comments#296565">
        <title>Circulating endothelial precursors and the hypoxia machinery. Reply to comments</title>
        <link>http://respiratory-research.com/content/8/1/58/comments#296565</link>
        <description>&lt;p&gt;Respiratory Research&lt;/p&gt;&lt;p&gt;Reply to comments December 24, 2007&lt;/p&gt;&lt;p&gt;Dear Dr Prakash,&lt;/p&gt;&lt;p&gt;Thank you for you interest in our paper that we believe that is the first linking in healthy subjects a simulated altitude [1] with the circulating endothelial precursors and the hypoxia machinery.Your comments give us the opportunity to clarify some aspects.&lt;/p&gt;&lt;p&gt;1. In our study we measured the SpotOxygen Saturation of haemoglobin(SpO2)by using a pulseoximeter. Pulseoximetry is the most convenient non-invasive method of monitoring arterial saturation continuously. Although there are many advantages of using pulse oximetry as a tool for monitoring oxygen saturation in arterial blood, there are also potential pitfalls.The pulsatile component of the signal represents the arterial absorption and forms only a small proportion of the total, the signal is thus very susceptible to noise, for example in association to movements and during fluctuations in ambient light that can produce false pulsatile signals; also carboxyhaemoglobin causes misreadings the pulsatile oximeter to overread. Furthermore, no absolute method for calibrating pulseoximeters yet exists, and manufacturers make use of specific equations obtained by comparing wavelength measurement with arterial blood samples from volunteers [2]. Nonetheless the measurement of the peripheral oxygen saturation of haemoglobin is considered a standard, therefore the SpO2 measurements we reported are affordable. The Alveolar Oxygen Partial Pressure(PAO2) values were measured by using a gasanalyzer, estimated indirectly by using the following equation:&lt;/p&gt;&lt;p&gt;PAO2=FiO2*(BP-47)-PaCO2/R&lt;/p&gt;&lt;p&gt;where: - FiO2 is the inhaled Fraction of oxygen- BP is the barometric pressure - PaCO2 is the arterial pressure of CO2 (derived from another formula) - R is the respiratory exchange rate. As you can see 47 is the pH2O that is considered as a constant in the formula, while both the hypoxicator and the gasanalyzer dried the air out during the test, so the volunteers breathed a low pH2O air. If you consider this and correct the formula with the pH2O value of 36, you obtain the data shown in table 1. Since hypoxia was applied to all subjects in the same experimental conditions of pH2O, in the table reported in the paper we preferred to show the data as calculated by the gasanalyzer, without changing the original equation. Therefore the PAO2 values accounting for a different pH2O could be derived simply by introducing a correction factor in the original equation.&lt;/p&gt;&lt;p&gt;2. The t-test is a useful tool for comparing the means of two groups; in our study we used the ANOVA test that is indicated when comparing 3 or more groups; furthermore, our samples are PAIRED, this fact means that individual values (same subjects) obtained before and after the test are compared; comparison of the means is not allowed in this model but only for UNPAIRED samples.&lt;/p&gt;&lt;p&gt;3. We agree that an arterial blood sample would have been useful but this procedure was not justified in healthy volunteers (students). Finally, many thanks to BMCO penAccess model that allows all researchers to discuss on-line their results.&lt;/p&gt;&lt;p&gt;References&lt;/p&gt;&lt;p&gt;1.Ciulla MM, et al.: Effects of simulated altitude (normobarichypoxia) on cardiorespiratory parameters and circulating endothelial precursors in healthy subjects. Respir Res 2007; 8:58.&lt;/p&gt;&lt;p&gt;2. Hutton P, Clutton-Brock T: The benefits and pitfalls of pulse oximetry. BMJ 1993, 307:457-458.&lt;/p&gt;&lt;p&gt;atmospheric air (baseline)&lt;/p&gt;&lt;p&gt;gas - P(mmHg) - Dry-fraction&lt;/p&gt;&lt;p&gt;O2 - 160 - 0,21 &lt;/p&gt;&lt;p&gt;CO2 - 0 - 0 &lt;/p&gt;&lt;p&gt;N2 - 588 - 0,79 &lt;/p&gt;&lt;p&gt;H2O - 12 - 0 &lt;/p&gt;&lt;p&gt;atmospheric air (hypoxia)&lt;/p&gt;&lt;p&gt;gas - P(mmHg) - Dry-fraction&lt;/p&gt;&lt;p&gt;O2 - 80 - 0,12&lt;/p&gt;&lt;p&gt;CO2 - 0 - 0&lt;/p&gt;&lt;p&gt;N2 - 672 - 0,88&lt;/p&gt;&lt;p&gt;H2O - 8 - 0&lt;/p&gt;&lt;p&gt;t0 alveolar air &lt;/p&gt;&lt;p&gt;gas - P(mmHg)&lt;/p&gt;&lt;p&gt;O2 - 100 &lt;/p&gt;&lt;p&gt;CO2 - 40 &lt;/p&gt;&lt;p&gt;N2 - 573 &lt;/p&gt;&lt;p&gt;H2O - 47 &lt;/p&gt;&lt;p&gt;Tot 760 &lt;/p&gt;&lt;p&gt;t0-t1 alveolar air&lt;/p&gt;&lt;p&gt;gas - P(mmHg)&lt;/p&gt;&lt;p&gt;O2 - 52&lt;/p&gt;&lt;p&gt;CO2 - 40&lt;/p&gt;&lt;p&gt;N2 - 632&lt;/p&gt;&lt;p&gt;H2O - 36&lt;/p&gt;&lt;p&gt;Tot 760&lt;/p&gt;</description>
                <dc:creator>Michele Ciulla</dc:creator>
                <dc:date>2008-03-04T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://respiratory-research.com/content/8/1/58/comments#285631">
        <title>Re: Effects of normobaric hypoxia on cardiorespiratory parameters and endothelial progenitor cells in peripheral blood in healthy subjects</title>
        <link>http://respiratory-research.com/content/8/1/58/comments#285631</link>
        <description>&lt;p&gt;Ciulla et al are complemented for their investigation of an important research question.&lt;/p&gt;&lt;p&gt;From data in Table 1, it is seen that oxygen saturation of hemoglobin is as high as 86.8% (mean value) when alveolar PO2 is as low as 30 mm Hg. Typically, the oxygen saturation of Hb A is expected to be as low as 50% when the arterial PO2 is 30 mm Hg [1]. Were the PAO2 values directly estimated by sampling end tidal alveolar gas? Or were they calculated from the alveolar gas equation? Anyway PaCO2 has not been estimated. &lt;/p&gt;&lt;p&gt;In Table 1 (on page 17 of the PDF version), it is mentioned that the concentration of endothelial precursor cells has increased from 0.38 +/- 0.56; [mean (SD)] to 0.65 +/-0.72 cells per microliter. The P value for this difference is noted as 0.016. From calculating a P value with just the mean and SD, for a sample size of 8, I got a P value of 0.42. &lt;/p&gt;&lt;p&gt;The increase in minute ventilation in response to hypoxemia is insignificant although this may be attributable to the fall in PaCO2 and rise in pH of blood. In this context, it would have been useful to have a sample of arterial blood sampled at the end of 1 hour of normobaric hypoxia. &lt;/p&gt;&lt;p&gt;References: &lt;/p&gt;&lt;p&gt;[1] Ciulla MM et al. Effects of simulated altitude (normobaric hypoxia) on cardiorespiratory&lt;/p&gt;&lt;p&gt;parameters and circulating endothelial precursors in healthy subjects. Respiratory Research 2007, 8:58; doi:10.1186/1465-9921-8-58&lt;/p&gt;&lt;p&gt;[2] Ganong WF. Review of Medical Physiology, International Edition, 2005, Mc Graw Hill Co., figure 35-2 in p. 667. &lt;/p&gt;</description>
                <dc:creator>E Sankaranarayanan Prakash</dc:creator>
                <dc:date>2007-11-14T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://respiratory-research.com/content/7/1/81/comments#236532">
        <title>Re: Pre-natal and post-natal exposure to respiratory infection and atopic diseases development: a historical cohort study.</title>
        <link>http://respiratory-research.com/content/7/1/81/comments#236532</link>
        <description>&lt;p&gt;We read the interesting study by Zutavern et al (1), approaching the problem of assessing the relationship between (exposure to) infections and allergic diseases in an original way by using population level data as a proxy for individual exposure. Exposure between the start of pregnancy and the first birthday was defined as a high incidence of acute respiratory infections in that period in the region (as reported by physicians to the surveillance system in the former German Democratic Republic). The study population included children (aged 5-14 years) born between 1977 and 1990 in three different regions in the former German Democratic Republic and was assessed between 1992 and 1999. &lt;/p&gt;&lt;p&gt;We think, however, that the authors have overlooked an important confounder when adjusting the relationship between exposure and allergic disease, i.e. year of assessment. For already some five years after the re-unification in 1990 there was an important increase in the prevalence of hay fever and atopic sensitization (2). &lt;/p&gt;&lt;p&gt;A second point is that they considered the number of siblings (or rather family size as a proxy variable) as a possible confounder, but the number of older siblings would have been more appropriate as the time frame under study was pregnancy and first year of life.&lt;/p&gt;&lt;p&gt;References&lt;/p&gt;&lt;p&gt;1. Zutavern A, von Klot S, Gehring U, Krauss-Etschmann S, Heinrich J: Pre-natal and post-natal exposure to respiratory infection and atopic diseases development: a historical cohort study. Respiratory Research 2006, 7:81.  &lt;/p&gt;&lt;p&gt;2. von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U: Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998;351:862-6.&lt;/p&gt;&lt;p&gt;Roos M.D. Bernsen PhD(1)&lt;/p&gt;&lt;p&gt;Johannes C. van der Wouden PhD(2)&lt;/p&gt;&lt;p&gt;1.	United Arab Emirates University&lt;/p&gt;&lt;p&gt;	Al Ain&lt;/p&gt;&lt;p&gt;	United Arab Emirates&lt;/p&gt;&lt;p&gt;	Department of Community Medicine&lt;/p&gt;&lt;p&gt;	&lt;/p&gt;&lt;p&gt;2.	Erasmus MC &amp;#8211; University Medical Center Rotterdam&lt;/p&gt;&lt;p&gt; 	The Netherlands&lt;/p&gt;&lt;p&gt;	Department of General Practice&lt;/p&gt;&lt;p&gt;	E-mail: j.vanderwouden@erasmusmc.nl&lt;/p&gt;</description>
                <dc:creator>Roos Maria Desirée Bernsen</dc:creator>
                <dc:date>2006-07-06T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://respiratory-research.com/content/6/1/135/comments#215506">
        <title>adjuvanted vaccines for bird flu counterindicated?</title>
        <link>http://respiratory-research.com/content/6/1/135/comments#215506</link>
        <description>&lt;p&gt;Recent research data suggests that the lethality of the H5N1 strain of avian influenza among young healthy adults may be due to its stimulation of an excessive immune response in the epithelial cells of the respiratory system. If this proves to be true, then might it not be counterindicated to provide a lower dose of flu vaccine with adjuvants to stimulate the immune system, as WHO has been proposing to the laboratories producing the vaccines as a solution to inadeqate supplies? The research paper suggests immune suppressors as a possible life saving treatment to those infected with the virus, therefore it would seem stimulating a stronger immune response with adjuvants might be a wrong approach. &lt;/p&gt;</description>
                <dc:creator>Mary Quijano</dc:creator>
                <dc:date>2005-11-26T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://respiratory-research.com/content/5/1/22/comments#104454">
        <title>Correction to Initials on Authors List</title>
        <link>http://respiratory-research.com/content/5/1/22/comments#104454</link>
        <description>&lt;p&gt;Could you please correct the initials of one of the authors on the web site and on the abstract to agree with the correct initials on the paper.&lt;/p&gt;&lt;p&gt;It should read E. K-Y. Walker.&lt;/p&gt;&lt;p&gt;Thank you for attention to this request.&lt;/p&gt;</description>
                <dc:creator>W. Alan Mutch</dc:creator>
                <dc:date>2004-11-25T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://respiratory-research.com/content/5/1/22/comments#102454">
        <title>Competing Interest Statement</title>
        <link>http://respiratory-research.com/content/5/1/22/comments#102454</link>
        <description>&lt;p&gt;See below.&lt;/p&gt;</description>
                <dc:creator>W. Alan Mutch</dc:creator>
                <dc:date>2004-11-24T00:00:00Z</dc:date>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
